| 15-LOX | 15-lipoxygenase |
| A1 | A1 phenotype astroglia |
| A2 | A2 phenotype astroglia |
| AAV | Anti-neutrophil cytoplasmic antibody-associated vasculitis |
| AD | Alzheimer’s disease |
| ALX/FPR2 | ALX/formyl peptide receptor 2 |
| AMPK | AMP-activated protein kinase |
| AP-1 | Activator protein 1 |
| Arg-1 | Arginase 1 |
| ASC | Apoptosis-associated speck-like protein containing a CARD |
| APC | Antigen-presenting cell |
| ATP | Adenosine triphosphate |
| Aβ | Amyloid beta |
| BAFF | B-cell activating factor |
| BBB | Blood–brain barrier |
| BDNF | Brain-derived neurotrophic factor |
| BIM | Bcl-2 interacting mediator of cell death |
| C1q | Complement component 1q |
| C3 | Complement component 3 |
| C3a | Complement component 3a |
| C3aR | Complement component 3a receptor |
| C3b | Complement component 3b |
| C5 | Complement component 5 |
| C5a | Complement component 5a |
| C5aR1 | Complement component 5a receptor 1 |
| cAMP | Cyclic adenosine monophosphate |
| CARD | Caspase activation and recruitment domain |
| CCL2 | Chemokine (C-C motif) ligand 2 |
| CD11b | Cluster of differentiation 11b |
| CD18 | Cluster of differentiation 18 |
| CD19 | Cluster of differentiation 19 |
| CD20 | Cluster of differentiation 20 |
| CD52 | Cluster of differentiation 52 |
| CD200 | Cluster of differentiation 200 |
| ChemR23 | Chemokine-like receptor 1 |
| CI | Confidence interval |
| c-Jun | c-Jun proto-oncogene |
| CNS | Central nervous system |
| COX | Cyclooxygenase |
| COX-1 | Cyclooxygenase 1 |
| COX-2 | Cyclooxygenase 2 |
| cPLA2 | Cytosolic phospholipase A2 |
| CR3 | Complement receptor 3 |
| CREB | cAMP response element-binding protein |
| CSF1R | Colony-stimulating factor 1 receptor |
| CX3CL1 | C-X3-C motif chemokine ligand 1 |
| CX3CR1 | C-X3-C motif chemokine receptor 1 |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| DAMP | Damage-associated molecular pattern |
| DHA | Docosahexaenoic acid |
| DNA | Deoxyribonucleic acid |
| EP | E-prostanoid receptor (PGE2 receptor) |
| EP1 | E-type prostanoid receptor 1 |
| EP2 | E-type prostanoid receptor 2 |
| EP3 | E-type prostanoid receptor 3 |
| EP4 | E-type prostanoid receptor 4 |
| EPA | Eicosapentaenoic acid |
| ERK | Extracellular signal-regulated kinase |
| FASL | Fas ligand |
| GPCR | G protein-coupled receptor |
| GPR32 | G protein-coupled receptor 32 |
| GR | Glucocorticoid receptor |
| GRE | Glucocorticoid response element |
| HMGB1 | High mobility group box 1 |
| Hsp | Heat shock protein |
| HSP70 | Heat shock protein 70 |
| HSP90 | Heat shock protein 90 |
| ICAM-1 | Intercellular adhesion molecule 1 |
| IFN-β | Interferon beta |
| IFNβ-1a | Interferon beta-1a |
| IGF-1 | Insulin-like growth factor 1 |
| IKK | IκB kinase |
| IKKε | IκB kinase epsilon |
| IL-10 | Interleukin 10 |
| IL-12 | Interleukin 12 |
| IL-17 | Interleukin 17 |
| IL-17A | Interleukin 17A |
| IL-1R | Interleukin 1 receptor |
| IL-1α | Interleukin 1 alpha |
| IL-1β | Interleukin 1 beta |
| IL-23 | Interleukin 23 |
| IL-6 | Interleukin 6 |
| IL-6R | Interleukin 6 receptor |
| iNOS | Inducible nitric oxide synthase |
| IRAK1 | Interleukin 1 receptor-associated kinase 1 |
| IRAK4 | Interleukin 1 receptor-associated kinase 4 |
| IRF | Interferon regulatory factor |
| IRF3 | Interferon regulatory factor 3 |
| IκBα | Inhibitor of κB alpha |
| JAK | Janus kinase |
| JNK | c-Jun N-terminal kinase |
| LC3 | Microtubule-associated protein 1A/1B-light chain 3 |
| LD | Lafora disease |
| LOX | Lipoxygenase |
| LXA4 | Lipoxin A4 |
| M1 | M1 phenotype microglia |
| M2 | M2 phenotype microglia |
| mAb | Monoclonal antibody |
| MaR1 | Maresin 1 |
| MAC | Membrane attack complex |
| MAPK | Mitogen-activated protein kinase |
| MMP | Matrix metalloproteinase |
| MMP-2 | Matrix metalloproteinase 2 |
| MMP-9 | Matrix metalloproteinase 9 |
| MRI | Magnetic resonance imaging |
| MS | Multiple sclerosis |
| MyD88 | Myeloid differentiation primary response 88 |
| NCLs | Neuronal ceroid lipofuscinoses |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B-cells |
| NLR | NOD-like receptor |
| NLRP3 | NLR family pyrin domain containing 3 |
| NMDA | N-methyl-D-aspartate |
| NMOSD | Neuromyelitis optica spectrum disorder |
| NO | Nitric oxide |
| NOX2 | NADPH oxidase 2 |
| NPSLE | Neuropsychiatric systemic lupus erythematosus |
| Nrf-2 | Nuclear factor erythroid 2-related factor 2 |
| NSAID | Non-steroidal anti-inflammatory drug |
| OPC | Oligodendrocyte precursor cell |
| OR | Odds ratio |
| P2X7 | Purinergic receptor P2X, ligand-gated ion channel 7 |
| P2Y12 | Purinergic receptor P2Y, G-protein coupled, 12 |
| p300 | E1A binding protein p300 |
| p38 | p38 mitogen-activated protein kinase |
| p50 | NF-κB p50 subunit |
| p53 | Tumor protein 53 |
| p65 | NF-κB p65 (RelA) subunit |
| PAMP | Pathogen-associated molecular pattern |
| PD | Parkinson’s disease |
| PD1 | Protectin D1 |
| PGE2 | Prostaglandin E2 |
| PGH2 | Prostaglandin H2 |
| PI3K/AKT | Phosphoinositide 3-kinase/Protein kinase B pathway |
| PPAR | Peroxisome proliferator-activated receptor |
| PPARγ | Peroxisome proliferator-activated receptor gamma |
| pro-IL-18 | Pro-interleukin 18 |
| pro-IL-1β | Pro-interleukin 1 beta |
| PRR | Pattern recognition receptor |
| PYD | Pyrin domain |
| Rac1 | Ras-related C3 botulinum toxin substrate 1 |
| RLR | RIG-I-like receptor |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| RR | Relative risk |
| RRMS | Relapsing–remitting multiple sclerosis |
| RvD1 | Resolvin D1 |
| RvE1 | Resolvin E1 |
| S100B | S100 calcium-binding protein B |
| SPM | Specialized pro-resolving mediators |
| SRC-1 | Steroid receptor coactivator-1 |
| STAT | Signal transducer and activator of transcription |
| STAT1 | Signal transducer and activator of transcription 1 |
| TBI | Traumatic brain injury |
| TBK1 | TANK-binding kinase 1 |
| TDP-43 | TAR DNA-binding protein 43 |
| TGF-β | Transforming growth factor beta |
| TLR | Toll-like receptor |
| TLR4 | Toll-like receptor 4 |
| TNFR1 | Tumor necrosis factor receptor 1 |
| TNFR2 | Tumor necrosis factor receptor 2 |
| TNF-α | Tumor necrosis factor alpha |
| TRAF6 | TNF receptor-associated factor 6 |
| TRIF | TIR-domain-containing adapter-inducing interferon beta |
| UPDRS | Unified Parkinson’s Disease Rating Scale |
| VCAM-1 | Vascular cell adhesion molecule 1 |
| VEGF | Vascular endothelial growth factor |